Gautam, Sanjivan
Fioravanti, Jessica http://orcid.org/0000-0001-6263-4306
Zhu, Wei
Le Gall, John B.
Brohawn, Philip
Lacey, Neal E. http://orcid.org/0000-0002-3633-5924
Hu, Jinhui
Hocker, James D.
Hawk, Nga Voong
Kapoor, Veena
Telford, William G.
Gurusamy, Devikala
Yu, Zhiya
Bhandoola, Avinash
Xue, Hai-Hui http://orcid.org/0000-0002-9163-7669
Roychoudhuri, Rahul http://orcid.org/0000-0002-5392-1853
Higgs, Brandon W. http://orcid.org/0000-0002-2951-0245
Restifo, Nicholas P.
Bender, Timothy P. http://orcid.org/0000-0001-9216-1212
Ji, Yun http://orcid.org/0000-0001-6340-7009
Gattinoni, Luca http://orcid.org/0000-0003-2239-3282
Article History
Received: 26 March 2018
Accepted: 19 December 2018
First Online: 18 February 2019
Competing interests
: P.B. and B.W.H. are full-time employees of MedImmune and have stock in AstraZeneca. S.G., Y.J. and L.G. have a pending patent on c-Myb technology.